Bioinks and 3D printed organs the focus of new CollPlant division

CollPlant, developer of plant-based rhCollagen technology for tissue repair, will be expanding its research into bioprinting organs and other tissues.

Go to the profile of Freya Leask
May 15, 2017
Upvote 0 Comment

Research into collagen-based bioinks will be the focus of a new division established by CollPlant (Israel). The inks are intended to be utilized in the production of 3D printed organs and other tissues. CollPlant’s proprietary rhCollagen technology utilizes genetically engineered tobacco plants to grow collagen tissues identical to the type I collagen produced by the human body. It is hoped this artificial collagecould offer a solution to tissue regeneration and repair.

Read the full story on 3DMedNet

Go to the profile of Freya Leask

Freya Leask

Publisher, Future Science Group

I am the Editor of RegMedNet, here to help users make the most of the website. I am passionate about digital and STM publishing, as well as regenerative medicine and medical 3D printing. Please get in touch if you have any queries or comments!

No comments yet.